NF1 and cancer: The NF1 loss-of-function (LOF) mutations occur in many cancer types, including pediatric cancers, with 10% to 15% of pediatric patients developing a low-grade glioma within the optic pathway and an additional 3% to 5% patients developing low-grade glioma outside of the optic pathway (17, 18).